Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Excellent tolerance to cilnidipine in hypertensives with amlodipine - induced edema.

Shetty R, Vivek G, Naha K, Tumkur A, Raj A, Bairy KL.

N Am J Med Sci. 2013 Jan;5(1):47-50. doi: 10.4103/1947-2714.106203.

2.

Comparison of amlodipine with cilnidipine on antihypertensive efficacy and incidence of pedal edema in mild to moderate hypertensive individuals: A prospective study.

Adake P, Somashekar HS, Mohammed Rafeeq PK, Umar D, Basheer B, Baroudi K.

J Adv Pharm Technol Res. 2015 Apr-Jun;6(2):81-5. doi: 10.4103/2231-4040.154543.

3.

Renal and vascular protective effects of cilnidipine in patients with essential hypertension.

Morimoto S, Yano Y, Maki K, Iwasaka T.

J Hypertens. 2007 Oct;25(10):2178-83.

PMID:
17885563
4.

Cilnidipine induced ankle edema.

Annil VR, Mahajan A, Mahajan V, Khajuria V, Gillani Z.

Indian J Pharmacol. 2014 May-Jun;46(3):348-9. doi: 10.4103/0253-7613.132202.

5.
6.
7.

Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel.

Shimizu H, Nakagami H, Yasumasa N, Mariana OK, Kyutoku M, Koriyama H, Nakagami F, Shimamura M, Rakugi H, Morishita R.

Hypertens Res. 2012 Jan;35(1):77-81. doi: 10.1038/hr.2011.143. Epub 2011 Sep 1.

PMID:
21881574
8.

Renoprotective and antioxidant effects of cilnidipine in hypertensive patients.

Soeki T, Kitani M, Kusunose K, Yagi S, Taketani Y, Koshiba K, Wakatsuki T, Orino S, Kawano K, Sata M.

Hypertens Res. 2012 Nov;35(11):1058-62. doi: 10.1038/hr.2012.96. Epub 2012 Jul 5.

PMID:
22763473
9.

Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats.

Aritomi S, Niinuma K, Ogawa T, Konda T, Nitta K.

Clin Exp Nephrol. 2013 Feb;17(1):41-50. doi: 10.1007/s10157-012-0677-4. Epub 2012 Aug 17.

PMID:
23011292
10.

The N- and L-type calcium channel blocker cilnidipine suppresses renal injury in dahl rats fed a high-sucrose diet, an experimental model of metabolic syndrome.

Konda T, Enomoto A, Matsushita J, Takahara A, Moriyama T.

Nephron Physiol. 2005;101(1):p1-13. Epub 2005 May 9.

PMID:
15886499
11.

Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte.

Fan YY, Kohno M, Nakano D, Ohsaki H, Kobori H, Suwarni D, Ohashi N, Hitomi H, Asanuma K, Noma T, Tomino Y, Fujita T, Nishiyama A.

J Hypertens. 2010 May;28(5):1034-43.

12.

A Comparative Study on Clinical and Biochemical Parameters in Amlodipine and Cilnidipine Treated Hypertensive Patients.

Shetty K, Shetty R, Bairy L, Rao P, Kiran A, Shetty M, Deepak, Nayak V.

J Clin Diagn Res. 2017 May;11(5):FC01-FC05. doi: 10.7860/JCDR/2017/23825.9763. Epub 2017 May 1.

13.

The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet.

Aritomi S, Koganei H, Wagatsuma H, Mitsui A, Ogawa T, Nitta K, Konda T.

Heart Vessels. 2010 Nov;25(6):549-55. doi: 10.1007/s00380-010-0005-4. Epub 2010 Oct 5.

PMID:
20922532
14.

Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure.

Hoshide S, Kario K, Ishikawa J, Eguchi K, Shimada K.

Hypertens Res. 2005 Dec;28(12):1003-8.

PMID:
16671340
15.

L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.

Toba H, Yoshida M, Tojo C, Nakano A, Oshima Y, Kojima Y, Noda K, Wang J, Kobara M, Nakata T.

Hypertens Res. 2011 Apr;34(4):521-9. doi: 10.1038/hr.2010.279. Epub 2011 Jan 27.

PMID:
21270815
16.

L/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease.

Abe M, Maruyama N, Suzuki H, Inoshita A, Yoshida Y, Okada K, Soma M.

Heart Vessels. 2013 Jul;28(4):480-9. doi: 10.1007/s00380-012-0274-1. Epub 2012 Aug 23.

PMID:
22914905
17.

Antiproteinuric effect of cilnidipine in hypertensive Japanese treated with renin-angiotensin-system inhibitors - a multicenter, open, randomized trial using 24-hour urine collection.

Miwa Y, Tsuchihashi T, Ohta Y, Tominaga M, Kawano Y, Sasaguri T, Ueno M, Matsuoka H.

Clin Exp Hypertens. 2010;32(6):400-5. doi: 10.3109/10641961003667914. Epub 2010 Sep 9.

PMID:
20828221
18.

Different effects of L/N-type and L-type calcium channel blockers on the renin-angiotensin-aldosterone system in SHR/Izm.

Konda T, Enomoto A, Aritomi S, Niinuma K, Koganei H, Ogawa T, Nitta K.

Am J Nephrol. 2009;30(2):155-61. doi: 10.1159/000210396. Epub 2009 Mar 27.

PMID:
19325231
19.

Comparison of the effects of cilnidipine and amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats.

Takatsu M, Hattori T, Murase T, Ohtake M, Kato M, Nashima K, Nakashima C, Takahashi K, Ito H, Niinuma K, Aritomi S, Murohara T, Nagata K.

J Hypertens. 2012 Sep;30(9):1845-55. doi: 10.1097/HJH.0b013e3283567645.

PMID:
22796710
20.

Effects of Cilnidipine on Heart Rate and Uric Acid Metabolism in Patients With Essential Hypertension.

Das A, Kumar P, Kumari A, Chandra S, Gari M, Singh N, Dey D.

Cardiol Res. 2016 Oct;7(5):167-172. doi: 10.14740/cr494w. Epub 2016 Nov 3.

Supplemental Content

Support Center